Docmorris Ag Stock Net Income

DOCM Stock   5.68  0.02  0.35%   
As of the 4th of February, DocMorris shows the Semi Deviation of 3.33, mean deviation of 2.69, and Downside Deviation of 3.5. DocMorris AG technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DocMorris AG mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if DocMorris AG is priced favorably, providing market reflects its regular price of 5.68 per share.

DocMorris Total Revenue

1.08 Billion

DocMorris' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DocMorris' valuation are provided below:
Gross Profit
230.3 M
Profit Margin
(0.11)
Market Capitalization
275.8 M
Enterprise Value Revenue
0.3352
Revenue
1.1 B
There are over one hundred nineteen available fundamental signals for DocMorris AG, which can be analyzed over time and compared to other ratios. All traders should should verify DocMorris' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Enterprise Value is likely to climb to about 488.3 M in 2026, whereas Market Cap is likely to drop slightly above 257.4 M in 2026. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-87.5 M-91.9 M
Net Loss-87.5 M-91.9 M
Net Loss-87.5 M-91.9 M
Net Loss(9.48)(9.96)
Net Income Per E B T 1.09  1.08 
Net Loss is likely to drop to about (91.9 M) in 2026. Net Loss is likely to drop to about (91.9 M) in 2026.
  
The evolution of Net Income for DocMorris AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how DocMorris compares to historical norms and industry peers.

Latest DocMorris' Net Income Growth Pattern

Below is the plot of the Net Income of DocMorris AG over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in DocMorris AG financial statement analysis. It represents the amount of money remaining after all of DocMorris AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is DocMorris' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocMorris' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (97.25 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

DocMorris Net Income Regression Statistics

Arithmetic Mean(49,685,119)
Coefficient Of Variation(153.98)
Mean Deviation59,416,375
Median(36,238,000)
Standard Deviation76,507,269
Sample Variance5853.4T
Range308M
R-Value(0.51)
Mean Square Error4607.5T
R-Squared0.26
Significance0.04
Slope(7,755,668)
Total Sum of Squares93653.8T

DocMorris Net Income History

2026-83.2 M
2025-87.5 M
2024-97.3 M
202382.3 M
2022-171.1 M
2021-225.7 M
2020-135.7 M

DocMorris Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for DocMorris is extremely important. It helps to project a fair market value of DocMorris Stock properly, considering its historical fundamentals such as Net Income. Since DocMorris' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DocMorris' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DocMorris' interrelated accounts and indicators.
It's important to distinguish between DocMorris' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocMorris should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocMorris' market price signifies the transaction level at which participants voluntarily complete trades.

DocMorris 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DocMorris' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DocMorris.
0.00
11/06/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/04/2026
0.00
If you would invest  0.00  in DocMorris on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding DocMorris AG or generate 0.0% return on investment in DocMorris over 90 days. DocMorris is related to or competes with IVF Hartmann, Coltene Holding, Newron Pharmaceuticals, Santhera Pharmaceuticals, Molecular Partners, Ascom Holding, and S H. DocMorris is entity of Switzerland. It is traded as Stock on SW exchange. More

DocMorris Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DocMorris' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DocMorris AG upside and downside potential and time the market with a certain degree of confidence.

DocMorris Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DocMorris' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DocMorris' standard deviation. In reality, there are many statistical measures that can use DocMorris historical prices to predict the future DocMorris' volatility.
Hype
Prediction
LowEstimatedHigh
1.755.689.61
Details
Intrinsic
Valuation
LowRealHigh
0.854.788.71
Details
Naive
Forecast
LowNextHigh
1.515.449.37
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.66-0.58-0.48
Details

DocMorris February 4, 2026 Technical Indicators

DocMorris AG Backtested Returns

DocMorris appears to be relatively risky, given 3 months investment horizon. DocMorris AG secures Sharpe Ratio (or Efficiency) of 0.0758, which denotes the company had a 0.0758 % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for DocMorris AG, which you can use to evaluate the volatility of the firm. Please utilize DocMorris' Mean Deviation of 2.69, downside deviation of 3.5, and Semi Deviation of 3.33 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DocMorris holds a performance score of 6. The firm shows a Beta (market volatility) of 1.1, which means a somewhat significant risk relative to the market. DocMorris returns are very sensitive to returns on the market. As the market goes up or down, DocMorris is expected to follow. Please check DocMorris' mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether DocMorris' price patterns will revert.

Auto-correlation

    
  -0.3  

Weak reverse predictability

DocMorris AG has weak reverse predictability. Overlapping area represents the amount of predictability between DocMorris time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DocMorris AG price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current DocMorris price fluctuation can be explain by its past prices.
Correlation Coefficient-0.3
Spearman Rank Test-0.23
Residual Average0.0
Price Variance0.11
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

DocMorris Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

703.43 Million

At this time, DocMorris' Accumulated Other Comprehensive Income is fairly stable compared to the past year.
Based on the recorded statements, DocMorris AG reported net income of (97.25 Million). This is much lower than that of the Consumer Staples Distribution & Retail sector and significantly lower than that of the Consumer Staples industry. The net income for all Switzerland stocks is notably higher than that of the company.

DocMorris Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocMorris' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocMorris could also be used in its relative valuation, which is a method of valuing DocMorris by comparing valuation metrics of similar companies.
DocMorris is currently under evaluation in net income category among its peers.

DocMorris Fundamentals

About DocMorris Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DocMorris AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocMorris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocMorris AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.